The meeting of molecular biology and advanced artificial intelligence is marking a historic turning point for medicine. This is not simply about more powerful tools, but about a real paradigm shift: we are moving from a science that observes and describes life to one that can predict it — and increasingly, design it. For decades, biomedical research relied on a slow and costly trial-and-error approach. Developing a new drug could take more than ten years and cost over $2 bill
